CLEAR CELL RENAL CELL CANCER (CCRCC)
Clinical trials for CLEAR CELL RENAL CELL CANCER (CCRCC) explained in plain language.
Never miss a new study
Get alerted when new CLEAR CELL RENAL CELL CANCER (CCRCC) trials appear
Sign up with your email to follow new studies for CLEAR CELL RENAL CELL CANCER (CCRCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Two-Pronged attack tested for Tough-to-Treat kidney cancer spread
Disease control Not yet recruitingThis study is testing a new combination of two drugs, envafolimab and lenvatinib, as the first treatment for people with advanced kidney cancer that has spread to the liver. The goal is to see if this two-drug approach can effectively control the cancer and is safe for patients. …
Matched conditions: CLEAR CELL RENAL CELL CANCER (CCRCC)
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC
-
Targeted radiation zaps recurrent kidney cancer in major new trial
Disease control Not yet recruitingThis study is testing a new targeted radiation drug called 177Lu-TLX250 for people with advanced kidney cancer that has returned or spread after at least two prior treatments. The drug is designed to find and deliver radiation directly to cancer cells. The trial will first find t…
Matched conditions: CLEAR CELL RENAL CELL CANCER (CCRCC)
Phase: PHASE3 • Sponsor: Telix Pharmaceuticals (Innovations) Pty Limited • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC